Shares of Catalyst Pharmaceuticals Inc. (CPRX) are up an impressive 179% year-to-date while the iShares NASDAQ Biotechnology Index ETF (IBB) has gained just 17% during the same period.
Original Article: In The Spotlight: Catalyst Pharmaceuticals
NEXT ARTICLE